Eve & Co Incorporated
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Melinda Rombouts
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 2941 Napperton Drive Strathroy ON Canada N7G 3H8
- IPO Date
- Jan 8, 2021
- Website
- evecannabis.ca
- Similar Companies
- Business
- Eve & Co Incorporated is a Canadian licensed cannabis producer primarily engaged in the cultivation, processing, and sale of cannabis products through its wholly owned subsidiary Natural MedCo Ltd. The company's core product offerings include dried cannabis, cannabis plants, and cannabis oil, with a focus on products marketed under its female-centric EVE brand. Eve & Co operates a large licensed greenhouse facility located in Strathroy, Ontario, and holds cultivation and processing licenses under the Canadian Cannabis Act. The company also holds a European Union certificate of Good Manufacturing Practice, underscoring its compliance with international quality standards. Founded in 2015 and headquartered in Strathroy, Canada, Eve & Co targets the medicinal and adult-use cannabis markets with a specialized emphasis on female consumers, positioning itself as a leading female-focused cannabis brand in the Canadian industry. The company has developed strategic collaborations, including a Medical Cannabis Supply and Purchase Agreement with TCann Pty Ltd. in Australia, expanding its geographic footprint and distribution network. In recent years, Eve & Co has undergone significant operational restructuring and financial processes, including court-approved sales and investment solicitation since 2022. These changes reflect a major strategic shift aimed at stabilizing and advancing its market position. Eve & Co continues to leverage its agricultural expertise with licensed greenhouse operations to maintain quality and supply chain control as it works through a transformative phase to enhance shareholder value and operational efficiency in the evolving cannabis industry. Eve & Co is publicly traded on the TSX Venture Exchange under the ticker EVE and on the OTCQX market as EEVVF. The company remains focused on growth opportunities within Canada and internationally by expanding its product offerings and market reach while maintaining compliance with regulatory standards.
Eve & Co Closes Shares For Debt Transaction Settling $657K In Payables Owed
Eve & Co. Announces Revenues of $4.0M in the First Half of 2021 and Financial Results for the Six Months Ended June 30, 2021
Eve & Co Announces Results of Annual General Meeting
Eve & Co Announces the Launch of a New Product The Optimist CBD Bath Bomb
Eve & Co Announces Operating Highlights and Financial Results for the Three Months Ended March 31, 2021
Eve & Co Announces Financial Results for the Year Ended December 31, 2020
Eve & Co Announces CAD$1M Private Financing
Eve & Co Announces Share Consolidation
Eve & Co Announces Licensing Agreement with Dr. Kerklaan Therapeutics
Eve & Co Completes Issuance of $550,000 Convertible Debentures
Eve & Co Announces Financial Results for the Three and Nine Months Ended September 30, 2020